chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Site: Pain at Injection Site-Mild, Additional Details: Patient reports that he experiences soreness on the side of the arm he received the 1st dose of Moderna vaccine when he moves his arm. He states it began 2 weeks after his 1st dose. He states pain is near his elbow.
all the symptoms of the flu; loss of appetite; headache; joint aches and pains; very tired; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (all the symptoms of the flu), DECREASED APPETITE (loss of appetite), HEADACHE (headache), ARTHRALGIA (joint aches and pains) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 062B21A, 013L20A and 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: FLU VACCINE VII on 09-Sep-2021. Concurrent medical conditions included Asthma and Hashimoto's disease.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Sep-2021, the patient experienced PYREXIA (fever) and CHILLS (chills). On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (all the symptoms of the flu), DECREASED APPETITE (loss of appetite), HEADACHE (headache), ARTHRALGIA (joint aches and pains) and FATIGUE (very tired). On 01-Oct-2021, CHILLS (chills) had resolved. On 02-Oct-2021, PYREXIA (fever) had resolved. At the time of the report, INFLUENZA LIKE ILLNESS (all the symptoms of the flu), DECREASED APPETITE (loss of appetite), HEADACHE (headache), ARTHRALGIA (joint aches and pains) and FATIGUE (very tired) outcome was unknown.            NO Concomitant medication was reported Patient did not take medication to treat symptoms. She had an elbow replacement in the right arm.
Development of severe jaundice which led to a reaction requiring bilirubin lights treatment and wearing eye mask which caused clogged tear ducts in 4-6 day old newborn. This is an ongoing condition commonly causing surgical repair and/or vision impairment.
Information was received on 15-FEB-2019 by a lawyer regarding a case in litigation, concerning a female patient, history not provided. In FEB-2016 at age 52, the patient was prescribed and administered ZOSTAVAX by a pharmacist at a pharmacy. In Mar-2016 the patient was treated by a physician at a medical office for shingles. Outcome was not provided. Additional information has been requested.
-this is a 79-year-old female with past medical history of hypertension, hyperlipidemia, rheumatoid arthritis, immunocompromised, peripheral neuropathy, osteoporosis, chronic pain.She came to the hospital with a chief complaint of progressive worsening generalized weakness over the last 3-4 days.  Patient reports that she also had some nausea but denies any episodes of vomiting.  Has intermittent subjective fevers and chills.  Denies any cough, chest pain, shortness of breath, palpitations, abdominal pain, burning or painful urination, diarrhea.  She is the primary caretaker of her husband.  Husband is also in the emergency room.  She was unable to take care of herself and the husband.  11/02/2021 tested positive  -this is a 79-year-old female with past medical history of hypertension, hyperlipidemia, rheumatoid arthritis, immunocompromised, peripheral neuropathy, osteoporosis, chronic pain.   She came to the hospital with a chief complaint of progressive worsening generalized weakness over the last 3-4 days.  Patient reports that she also had some nausea but denies any episodes of vomiting.  Has intermittent subjective fevers and chills.  Denies any cough, chest pain, shortness of breath, palpitations, abdominal pain, burning or painful urination, diarrhea.  She is the primary caretaker of her husband.  Husband is also in the emergency room.  She was unable to take care of herself and the husband.  Due to worsening weakness she decided come to the hospital for further evaluation and treatment.
p/vax pt presented w/large area of erythema in area of inj; was hot & tender;sx began 2 days p/vax;
SEVERE PAIN/SHOCK FROM SITE TO END OF FINGERS, DURING INJECTION.  THEN FROZEN SHOULDER WITH SEVERE PAIN 3 HOURS LATER.  PAIN SINCE, CAUSING EXTREME INSOMNIA.  ORAL STEROIDS, PHYSICAL THERAPY, STEROID INJECTION.  LINGERING PAIN WITH MOBILITY ISSUES.
This is a spontaneous report from a contactable retired registered nurse (RN) who reported similar events for herself and for her husband. This is the first of two reports. This 78-year-old female patient received PREVNAR 13 on 12Jun2017 in the morning, at single dose, in the right deltoid, for immunisation. No vaccinations were given within 4 weeks prior. Medical history included rheumatoid arthritis (diagnosed in either 2008 or 2009) and Raynaud's. The patient previously took pneumococcal vaccine a couple of years before the report, yellow fever vaccine a few years ago and influenza vaccine regularly, all for immunization, with no adverse events. Family history was none. Concomitant medications included oral hydroxychloroquine tablets, since 2009 and ongoing, at 200 mg, 1x/day, for rheumatoid arthritis and acetylsalicylic acid ongoing since an unknown date, 81 mg, 1x/day, for Raynaud's. A blood work done on an unknown date in 2017 (a month or two prior vaccinations) showed up nothing worth mentioning. Since 29Jun2017 the patient began to feel fatigued and did not feel well. On 01Jul2017 at night the patient experienced fever, chills, hyperventilation. Since an unspecified date in 2017 she was having no appetite, spent 3 days in bed and was not being able to talk right at the time of report. She had been taking ibuprofen for the past couple of days and it had been helping. The events did not require emergency room or physician office visit. Speech disorder had not yet resolved at the time of report. Fever, chills and hyperventilation resolved on an unspecified date in Jul2017 and lasted about 12 hours. When her husband took her temperature on an unspecified date in Jul2017 at night it was only 99 (unspecified unit). The other events were resolving at the time of report. Sender's Comments: Linked Report(s) : US-PFIZER INC-2017293442 same reporter, different patient, same drug, similar events.
Swollen Face - a few days. Lip Swelling - a few days. Hives from onset until present (they appear and disappear all over my body and in crevices). Diarrhea from onset until the end of September. Severe Itching and discomfort from onset until mid October.
RESIDENT COMPLAINS OF BODY ACHES AND HURTS TO MOVE. RESOLVED WITHIN 24 HOURS.
I administered ZOSTAVAX Sub-Q in left arm on 6/2/15 to the patient. Patient called on 6/3 reporting redness, firmness at injection site and mild fever. I recommended icing site and TYLENOL/ibuprofen for fever and monitor site. She came in on 6/5. Redness had spread, firmness still present, and low grade fever continued. I referred her to Primary Care Physician for evaluation. PCP diagnosed infection at site and ordered course of antibiotics.
queasy stomach; fever; body aches; runs; sick as a dog; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick as a dog), FATIGUE (fatigue), ABDOMINAL DISCOMFORT (queasy stomach), PYREXIA (fever) and PAIN (body aches) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011AZ1A and 062G20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Jan-1949, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced ILLNESS (sick as a dog), FATIGUE (fatigue), PYREXIA (fever), PAIN (body aches) and DIARRHOEA (runs). On 08-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (queasy stomach). On 01-Mar-2021, ILLNESS (sick as a dog), PYREXIA (fever), PAIN (body aches) and DIARRHOEA (runs) had resolved. At the time of the report, FATIGUE (fatigue) and ABDOMINAL DISCOMFORT (queasy stomach) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Tylenol, Ginger, Hydrocortisone gel.
Patient was administered Pfizer vaccination at 0740.  0748: Exhibited symptoms of allergic reaction.  0748: 50mg PO Benadryl administered, Epi (.3mg/.3mL) administered. Patient began vomiting, O2  2L Nasal Canula applied.  0751: Epi (.3mg/3mL) administered. 0752: Benadryl 50mg IM administered.  0755: EMS arrived.  0800: 8mg Decadron IM and 40mg Kenelog IM administered.
Patient reports feeling chills from the evening after the injection for three days.  Day 3 following the injection patient reported feeling very itchy and only found relief taking OTC Benedryl.  Day 5 following the injection patient reports having diarrhea that continues to bother her now.
This spontaneous report as received from a healthcare worker refers to a 15 year old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 08-JUL-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (lot # K023432, expiry date 18-JUN-2016) (strength, dose, route and site of administration were not provided). On 11-SEP-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot # L000610, expiry date: 31-JAN-2017) (strength, does, route and site of administration were not provided). No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
Hospitalized 11/29/2021-still admitted currently; COVID-19 positive 11/29/2021; fully vaccinated  CHIEF COMPLAINT: Shortness of breath      Assessment/Plan     ASSESSMENT / PLAN: COVID-19 pneumonia Acute on chronic respiratory failure with hypoxia              -- > Symptom onset:  11/23              -- > COVID 19 positive:  11/29              -- > Vaccination status:  Not vaccinated - Requires 2-3 L of oxygen at baseline, stable on 2 L at rest, desaturated in the ER with ambulation - Chest x-ray (11/29):  Cardiac silhouette mildly enlarged, no overt pulmonary edema. - NT-BNP and procalcitonin pending - Check sputum culture    Plan: - Will not start remdesivir given onset of symptoms 7 days ago and borderline adequate renal function with an eGFR of 37 - Start Decadron 6 mg IV daily for 10 days - DVT prophylaxis with subcutaneous heparin - Prone positioning as tolerated, incentive spirometry hourly - Trend CRP and D-dimer daily for 3 days - Supportive measures - Monitor continuous pulse oximetry, wean oxygen as able Care Management note 12/6/2021: Plan: transfer tomorrow 12/7/2021 to Facility at 1pm with transport pending insurance authorization
Left brachial Plexus tumor encompassing the left axillary artery; left axillary vein and the entire brachial plexus.  The tumor is unable to be separated from these main structures in the left axillary area.  Multiple lymph node involvement with metastasis to the node between the 1 and 2nd ribs of the chest.
her arm started to itch again. It was slightly red, hot, and itchy.; Arm started to itch again; her arm started to itch again. It was slightly red, hot, and itchy.; she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (her arm started to itch again. It was slightly red, hot, and itchy.), VACCINATION SITE PRURITUS (she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again), VACCINATION SITE PRURITUS (Arm started to itch again) and VACCINATION SITE ERYTHEMA (her arm started to itch again. It was slightly red, hot, and itchy.) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again). On 07-Mar-2021, the patient experienced VACCINATION SITE WARMTH (her arm started to itch again. It was slightly red, hot, and itchy.), VACCINATION SITE PRURITUS (Arm started to itch again) and VACCINATION SITE ERYTHEMA (her arm started to itch again. It was slightly red, hot, and itchy.). On 03-Mar-2021, VACCINATION SITE PRURITUS (she briefly experienced itching in her arm which eventually went away after 20 minutes/Arm started to itch again) had resolved. At the time of the report, VACCINATION SITE WARMTH (her arm started to itch again. It was slightly red, hot, and itchy.), VACCINATION SITE PRURITUS (Arm started to itch again) and VACCINATION SITE ERYTHEMA (her arm started to itch again. It was slightly red, hot, and itchy.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
SIRVA . Injected incorrectly 1cm below acromin process.  2hrs post injection severe pain (even now), immobility of joint, severe ROM limitation. Unable to perform ADLs.  Severe pain
DYSENTERY FOR THREE WEEKS; This spontaneous report received from a patient concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was previously dosed with semi-full strands of RNA. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose, one total, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced dysentery for three weeks. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dysentery for three weeks. This report was serious (Other Medically Important Condition).; Sender's Comments: V0:20211042943-Covid-19 vaccine ad26.cov2.s- Dysentery. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
c/o sudden pain to L anterior neck within 4 hrs after injection. By 9/17 noted to have mass to L anterior cervical neck, suspected lymph node. Advised to take OTC ibuprofen tid for the next 48hrs and to call back if develops significant SOB/weakness/extending rash of the arm.
15-20 minutes post vaccine administration, patient experienced numbness, tingling of cheeks and lips - "very subtle".  Lasted one hour then subsided.  No return to numbness or tingling as of 1/28/21.
pt recvd vax & had an erythematous area w/induration of 44mm @ inject site LLT-mom states disappeared in 2days-no fever or irritability;
Received shots 8/22/04. Noticed arm swollen. 9/28 afternoon. Temperature 100 degrees F. Red at injection. Swollen, hard.
MINIMAL REACTION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced minimal reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of minimal reaction was not reported. This report was non-serious.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and unknown gender. The patient's concurrent conditions and drug allergies were none. On 22-DEC-2015, the patient was vaccinated with ROTATEQ via oral route (strength, dose number and dosing regimen unknown). Concomitant medications were none. On the same day, 22-DEC-2015, shortly after vaccinated with ROTATEQ the patient regurgitated. No diagnostic tests were performed. The patient did not sought medical attention and no treatment was provided for the events. The outcome of the event was unknown. The relatedness of the event with ROTATEQ was not reported. No product quality complaint (PQC) was reported. Additional information has been requested.
Initial report received from a health care professional on 05 Aug 2010: This patient received only the conjugate component (without the vaccine) of MENVEO (batch number: not reported), (dose: unknown) intramuscularly on an unspecified date.
lt arm sore 3FEB99;fever Wednesday PM & Thursday 9no temp taken just warm) Thursday @ site of shot red circle around shot site;Friday, Saturday & Sunday redness progressed to elbow & shoulder;told by MD allergic to DTAP;
extreme pain; large area of redness on left arm increasing to area going around arm; arm area very hard; fever recorded at 101.6; nausea with some vomiting; aches; severe pain in back of head and along neck area; stiffness in shoulders and neck; used ice packs on arm; took tylenol; could only keep down Sprite, mashed potatoes, crackers; on Sun Sept. 30  went to ER where I received medication by mouth for swelling of arm and given 2 prescriptions for swelling, itching
I got the PNEUMOVAX 23 vaccine today and about 5 minutes later got really hot, dizzy, redness covering all of my skin, and throat tightening. No difficulty or breathing at that point, but it felt like someone was trying to strangle me from the inside.
Received shot around 5:30 PM on Friday, felt 10' tall that night, lots of energy. Woke up Saturday AM, hurt all over, injection site looked like a softball had hit my arm. Area was angry red, hot, did not have to touch the area to feel the heat. Did not take my fever. Saturday and Sunday were spent down and out. Injection site on Monday was still angry red, and you did not have to touch it to feel the heat. Felt like a mac truck had hit me. Worked less hours the whole week. Heat came out of the injection site mid week, by Friday the swelling had gone done.
This case was reported by a physician and described the occurrence of elevated liver enzymes in a patient who received FLUARIX TETRA. Previously administered products included FLUARIX. In 2014, the patient received FLUARIX TETRA. On an unknown date, unknown after receiving FLUARIX TETRA, the patient experienced elevated liver enzymes, aspartate aminotransferase increase and alanine aminotransferase increased. On an unknown date, the outcome of the elevated liver enzymes, aspartate aminotransferase increased and alanine aminotransferase increased were unknown. It was unknown if the reporter considered the elevated liver enzymes, aspartate aminotransferase increased and alanine aminotransferase increased to be related to FLUARIX TETRA. Additional information received: Post liver transplant patient who has developed elevated liver tests (elevated AST ALT to 5X ULN) after influenza vaccination both in 2013 and 2014.
Fussy after shots, took a nap. Parent woke child to go out to eat while driving, child was fussy, then suddenly stopped. Mom looked at child: acted like she fell asleep, but her face looked funny. Mom shook child 20-30 sec and woke her. Fussy again. Ate a little , but mom still worried. Called doctor and was advised to go to ER. Child acted okay while there, lab and EKG were WNL. Advised to watch child and report any worries.
Pt recvd 3 doses of Engerix-B vax & was determined to be a non-responder; pt recvd booster dose of Engerix-B;
7days after the injection , on January 29, my heart rate spiked and I had to have cardio version.    My second shot  was on February 19. Seven days later my heart rate spiked again and I had to have cardio version again.
Pain starting at injection site that worsen and developed to include the arm and left side of her torso making sleeping difficult. Per patient, no redness or rash.
I have them right now, I got them on my stomach and back; pain; blisters; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles) and hospitalization (got out of the hospital back in 2018).   In September 2022, the patient received Flu vaccine. In September 2022, 48 hrs after receiving Flu vaccine, the patient experienced shingles, pain and blister. On an unknown date, the outcome of the shingles was not recovered/not resolved and the outcome of the pain and blister were unknown.   It was unknown if the reporter considered the shingles, pain and blister to be related to Flu vaccine.     Additional Information: GSK receipt date: 22-Sept-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient have had them right now 48 hours after he/she got my flu shot. It started with the pain and then the blisters. The patient stated that have not had this bad ,since he/she got out of the hospital back in 2018. This time he/she got them on my stomach and back, totally a different place than usually.  Now the patient could not get his/her COVID booster until they clear up and could not get shingles shot for 2 to 6 weeks.  Since covid this was what the patient have to deal with booster or shingle shot.  The patient stated that knew patient's pain. Additional supportive information: The follow-up could not be possible as no contact details were available. As it was stated that right now have had shingles 48 hours after shot according to that vaccination date and onset date was captured as September 2022.
This case was reported by a nurse and described the occurrence of bronchospasm in a 63 year old female pt who received Engerix-B. On 1/13/04, the pt received the 3rd dose of Engerix-B (lot ENG5394A2). "Shortly" following vaccination, the pt experienced flu-like symptoms, nausea, headache, runny nose and a fever of 99F. The events resolved within one week of onset. On 1/21/04, the pt reported onset of new symptoms that she described as "laryngitis", including hoarseness. At an unspecified time following the 3rd dose of Engerix-B, the pt was dx'd with influenza A. Her illness persisted and she was subsequently dx'd with bronchitis and bronchospasm. Hoarseness persisted at the time of reporting; however, the outcome of the remaining events was not reported.
Left arm red and swollen where shots were given on 08/25/2006.  Arm firm, fever.
About 7 hours after the shot, I started to feel very tired and developed a fever which got worse and worse at night. It was so bad at night that I took an advil which helped tremendously. I also felt a little nausea and aches.
Fatigue, Cough Narrative:  On the day of vaccination patient reported cough and fatigue. Went and received a chest x-ray.